Treatment of difficult-to-heal wounds with stem cells included in a gel consistency dressing

2023-505017-25-02 Protocol THC0721 Phase I and Phase II (Integrated) - First administration to humans Ongoing, recruiting

Start 10 Jun 2024 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites · Protocol THC0721

Overview

Sponsor-declared trial summary

Phase Phase I and Phase II (Integrated) - First administration to humans
Status Ongoing, recruiting
Participants planned 10
Countries 1
Sites 1

Hard-to-heal-wounds

Key facts

Sponsor
Fundacion Para La Investigacion Y La Innovacion Biosanitaria Del Principado De Asturias
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Skin and Connective Tissue Diseases [C17]
Trial duration
10 Jun 2024 → ongoing
Decision date (initial)
2024-03-22
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Hard-to-heal-wounds

VersionLevelCodeTermSystem organ class
21.1 LLT 10048036 Wound healing delayed 10018065

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Fundacion Para La Investigacion Y La Innovacion Biosanitaria Del Principado De Asturias

3 Total trials 1 Recruiting
Academic / Non-commercial
Sponsor organisation
Fundacion Para La Investigacion Y La Innovacion Biosanitaria Del Principado De Asturias
Address
Avenida De Roma Sn
City
Oviedo
Postcode
33011
Country
Spain

Scientific contact point

Organisation
Fundacion Para La Investigacion Y La Innovacion Biosanitaria Del Principado De Asturias
Contact name
Silvia Perez Lopez

Public contact point

Organisation
Fundacion Para La Investigacion Y La Innovacion Biosanitaria Del Principado De Asturias
Contact name
Faustino Blanco

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Spain Ongoing, recruiting 10 1
Rest of world 0

Investigational sites

Spain

1 site · Ongoing, recruiting
Hospital Universitario Central De Asturias
Unidad de Terapia Celular y Medicina Regenerativa, Avenida De Roma S/n, 33011, Oviedo

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Spain 2024-06-10 2024-06-10

Application history

3 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2023-12-04 Spain Acceptable
2024-03-22
2024-03-22
2 SUBSTANTIAL MODIFICATION SM-2 2025-02-10 Spain Acceptable
2025-05-08
2025-05-08
3 SUBSTANTIAL MODIFICATION SM-4 2026-04-13 Spain Acceptable
2026-05-27
2026-06-01